A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread across the world. We report the clinical characteristics of 82 cases of death from COVID-19 in a single center. Clinical data on 82 death cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital’s electronic medical records according to previously designed standardized data collection forms. All patients were local residents of Wuhan, and a large proportion of them were diagnosed with severe illness when admitted. Due to the overwhelming of our system, a total of 14 patients (17.1%) were treated in the ICU, 83% of deaths never received Critical Care Support, only 40% had mechanical ventilation support despite 100% needing oxygen and the leading cause of death being pulmonary. Most of the patients who died were male (65.9%). More than half of the patients who died were older than 60 years (80.5%), and the median age was 72.5 years. The bulk of the patients who died had comorbidities (76.8%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%). Respiratory failure remained the leading cause of death (69.5%), followed by sepsis/MOF (28.0%), cardiac failure (14.6%), hemorrhage (6.1%), and renal failure (3.7%). Furthermore, respiratory, cardiac, hemorrhagic, hepatic, and renal damage were found in 100%, 89%, 80.5%, 78.0%, and 31.7% of patients, respectively. On admission, lymphopenia (89.2%), neutrophilia (74.3%), and thrombocytopenia (24.3%) were usually observed. Most patients had a high neutrophil-to-lymphocyte ratio of >5 (94.5%), high systemic immune-inflammation index of >500 (89.2%), and increased C-reactive protein (100%), lactate dehydrogenase (93.2%), and D-dimer (97.1%) levels. A high level of IL-6 (>10 pg/ml) was observed in all detected patients. The median time from initial symptoms to death was 15 days (IQR 11–20), and a significant association between aspartate aminotransferase (p = 0.002), alanine aminotransferase (p = 0.037) and time from initial symptoms to death was remarkably observed. Older males with comorbidities are more likely to develop severe disease and even die from SARS-CoV-2 infection. Respiratory failure is the main cause of COVID-19, but the virus itself and cytokine release syndrome-mediated damage to other organs, including cardiac, renal, hepatic, and hemorrhagic damage, should be taken seriously as well.
【초록키워드】 COVID-19, SARS-CoV-2, Respiratory failure, Clinical characteristics, Pneumonia, IL-6, SARS-COV-2 infection, Cancer, neutrophil, Comorbidities, Comorbidity, C-reactive protein, D-dimer, oxygen, Sepsis, Local, cytokine, diabetes, virus, hypertension, lactate dehydrogenase, ICU, Cytokine release syndrome, Neutrophil-to-lymphocyte ratio, lymphopenia, Spread, lymphocyte, clinical, Wuhan, male, Patient, death, Aspartate aminotransferase, age, thrombocytopenia, respiratory, cause of death, disease, Admission, patients, association, Lactate, renal failure, Data collection, severe disease, heart disease, Cerebrovascular disease, hemorrhage, followed by, on admission, medical records, initial symptoms, renal damage, cardiac failure, alanine aminotransferase, initial symptom, death case, Hemorrhagic, Older, Clinical data, median time, Most patients, median age, aspartate, other organs, Alanine, single center, neutrophilia, hemorrhagic damage, mechanical ventilation support, cytokine release, renal, laboratory-confirmed, MOST, systemic immune-inflammation index, forms, electronic medical record, Wuhan, China, develop, caused, died, proportion, the patient, remained, diagnosed, Most patient, treated, diabete, detected patients, IQR, the median, Wuhan local hospital’, 【제목키워드】 COVID-19, Characteristics, clinical, death,